These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23619838)

  • 1. Osteonecrosis snapshot.
    Ryan P
    Br Dent J; 2013 Apr; 214(8):373-4. PubMed ID: 23619838
    [No Abstract]   [Full Text] [Related]  

  • 2. United Kingdom nationwide study of avascular necrosis of the jaws including bisphosphonate-related necrosis.
    Rogers SN; Palmer NO; Lowe D; Randall C
    Br J Oral Maxillofac Surg; 2015 Feb; 53(2):176-82. PubMed ID: 25497376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteonecrosis of the jaws.
    Toole J
    Rheumatology (Oxford); 2015 Oct; 54(10):1755-6. PubMed ID: 25877909
    [No Abstract]   [Full Text] [Related]  

  • 4. Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate.
    Ulmner M; Jarnbring F; Törring O
    J Oral Maxillofac Surg; 2014 Jan; 72(1):76-82. PubMed ID: 23992777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteonecrosis of the jaw after oral bisphosphonate for osteoporosis.
    Tong CK; Ho ST; Wong SL
    Hong Kong Med J; 2010 Apr; 16(2):145-8. PubMed ID: 20354251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan.
    Yuh DY; Chang TH; Huang RY; Chien WC; Lin FG; Fu E
    J Dent; 2014 Oct; 42(10):1343-52. PubMed ID: 24907558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug induced osteonecrosis of the jaw.
    Hamadeh IS; Ngwa BA; Gong Y
    Cancer Treat Rev; 2015 May; 41(5):455-64. PubMed ID: 25913713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
    Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
    Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiologic studies are needed to clarify whether dental modalities could be predictors of bisphosphonate osteonecrosis of the jaw in breast cancer patients.
    Kyrgidis A; Andreadis C
    Oncologist; 2009 Jan; 14(1):101-2; author reply 103. PubMed ID: 19182244
    [No Abstract]   [Full Text] [Related]  

  • 11. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.
    Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons
    J Oral Maxillofac Surg; 2007 Mar; 65(3):369-76. PubMed ID: 17307580
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of bisphosphonate-related osteonecrosis of the jaw in Hong Kong.
    Kwok T; Choy TK; Kwok WL
    Hong Kong Med J; 2016 Feb; 22 Suppl 2():S46-7. PubMed ID: 26908345
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk of atypical femoral fractures and osteonecrosis of the jaw associated with alendronate use compared with other oral bisphosphonates.
    Kharazmi M; Hallberg P; Warfvinge G; Michaëlsson K
    Rheumatology (Oxford); 2014 Oct; 53(10):1911-3. PubMed ID: 25099769
    [No Abstract]   [Full Text] [Related]  

  • 14. Bisphosphonate related osteonecrosis of the jaws.
    Fung E
    J Rheumatol; 2009 Feb; 36(2):450; author reply 453. PubMed ID: 19208578
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence of serious side effects with intravenous bisphosphonate: a clinical audit.
    Powell D; Bowler C; Roberts T; Garton M; Matthews C; McCall I; Davie M
    QJM; 2012 Oct; 105(10):965-71. PubMed ID: 22753670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Going on a drug holiday?
    Bonnick SL
    J Clin Densitom; 2011; 14(4):377-83. PubMed ID: 22051091
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention and treatment of bisphosphonate-induced jaw bone osteonecrosis. II].
    Fogorv Sz; 2014 Sep; 107(3):106-7. PubMed ID: 25509512
    [No Abstract]   [Full Text] [Related]  

  • 18. Zoledronic acid and osteonecrosis of the jaw: incidence varies with use.
    Wynn RL
    Gen Dent; 2011; 59(5):330-2. PubMed ID: 22313815
    [No Abstract]   [Full Text] [Related]  

  • 19. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.
    Ruggiero SL; Dodson TB; Assael LA; Landesberg R; Marx RE; Mehrotra B;
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):2-12. PubMed ID: 19371809
    [No Abstract]   [Full Text] [Related]  

  • 20. [The risk of bisphosphonate-related osteonecrosis of the jaw].
    Polymenidi I; Trombetti A; Carballo S
    Rev Med Suisse; 2014 Oct; 10(446):1930-4. PubMed ID: 25438377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.